Latest Breaking News On - Monica rouco molina - Page 1 : comparemela.com

Revolo Biotherapeutics Presents New Data on '1805 at the American College of Rheumatology Convergence 2023 Annual Conference

Revolo Biotherapeutics Presents New Data on '1805 at the American College of Rheumatology Convergence 2023 Annual Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-diego
California
United-states
San-diego-convention-center
Cambridge
Cambridgeshire
United-kingdom
Monica-rouco-molina
Yuriko-yamamura
Revolo-biotherapeutic
Revolo-biotherapeutics
Carl-goodyear

GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023

GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Spain
China
Barcelona
Comunidad-autonoma-de-cataluna
United-states
America
Spanish
Monica-rouco-molina
Lifesci-communications
National-institutes-of-health
Grifols-press-office
National-cancer-institute

Revolo Biotherapeutics to Host Virtual KOL Event on '1104: A First-in-Class Peptide for Eosinophilic Esophagitis (EoE) and Allergic Disease

Revolo Biotherapeutics to Host Virtual KOL Event on '1104: A First-in-Class Peptide for Eosinophilic Esophagitis (EoE) and Allergic Disease
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
Cambridge
Cambridgeshire
Massachusetts
United-states
Evans-dellon
Revolo-biotherapeutics
Revolo-biotherapeutic
Marylyn-rigby
Mohamed-shamji

Revolo Biotherapeutics Announces Additional Data from Phase 2a Trial of '1104 in Adults with Active Eosinophilic Esophagitis

Revolo Biotherapeutics Announces Additional Data from Phase 2a Trial of '1104 in Adults with Active Eosinophilic Esophagitis
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Cambridge
Cambridgeshire
Monica-rouco-molina
Jonathan-rigby
Revolo-bio
Evan-dellon
Marylyn-rigby
Revolo-biotherapeutics
Revolo-biotherapeutic
University-of-north-carolina-chapel-hill
Company-contact